Curis, Inc. Profile Avatar - Palmy Investing

Curis, Inc.

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, whic…

Biotechnology
US, Lexington [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Curis, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Curis, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Curis, Inc..

End of CRIS's Analysis
CIK: 1108205 CUSIP: 231269200 ISIN: US2312693094 LEI: - UEI: -
Secondary Listings
CRIS has no secondary listings inside our databases.